(Q42983809)

English

Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection

scientific article published on February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

Angelo Andriulli

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Alessandra Mangia

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Nicola Minerva

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Donato Bacca

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Raffaele Cozzolongo

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ernesto Agostinacchio

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Fernando Sogari

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Gaetano Scotto

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Francesco Vinelli

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Giovanni Luciano Ricci

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Mario Romano

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Vito Carretta

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Daniela Petruzzellis

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

1 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

358-363

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Short-term treatment duration for HCV-2 and HCV-3 infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Peginterferon and ribavirin for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Shortened therapy for hepatitis C virus genotype 2 or 3--is less more?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22679

21 January 2018

Identifiers

10.1002/HEP.22679

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42983809&oldid=1975849975"